Dyadic International (NASDAQ:DYAI) Announces Earnings Results

Dyadic International (NASDAQ:DYAI) announced its quarterly earnings results on Tuesday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.06, Zacks reports. The company had revenue of $1.96 million during the quarter, compared to the consensus estimate of $1.05 million. Dyadic International had a negative return on equity of 140.01% and a negative net margin of 188.09%. During the same period in the previous year, the business earned ($0.06) EPS.

Dyadic International Stock Performance

Shares of DYAI stock traded down $0.02 during mid-day trading on Wednesday, hitting $1.12. 22,804 shares of the stock were exchanged, compared to its average volume of 47,767. The stock’s fifty day simple moving average is $1.13 and its two-hundred day simple moving average is $1.42. The company has a debt-to-equity ratio of 1.72, a quick ratio of 5.39 and a current ratio of 5.39. Dyadic International has a 12-month low of $0.93 and a 12-month high of $2.67.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.